- 5.4.1. Obligation to maintain Eligible Capital at or above MCR
- 5.4.2. Obligation to maintain Eligible Capital at or above PCR
- 1.5.4. Obligation to maintain Eligible Capital
- 4.2.1. ORSA Report - requirements
- 5.2.1. Obligation to calculate Eligible Capital
- 5.4.1. Obligation to maintain Eligible Capital at or above MCR
- 5.4.4. Non-Compliance with the MCR
- 5.4.2. Obligation to maintain Eligible Capital at or above PCR
- 5.4.3. Non-Compliance with the PCR
- 14.4.4. Eligible Capital of a Protected Cell Company
- 2.2. Eligible Capital Calculation Table
- 2.1. Calculating Eligible Capital
- 5.4.5. Other regulatory actions not precluded
- 5.4.7. Eligible Capital below the level of the Capital Floor
- 5.5.1. Tier 1 Capital not to be reduced without approval
- 10.1.6. Certain transactions to be inquired into by Insurer’s Governing Body
- 4.2. Subordinated debt
- 4.3. Legal opinions on Tier 2 Capital instruments
- 5.3. Inadmissible assets
- 4.4. Excluded assets
- 1.5.4. Obligation to maintain Eligible Capital
- 4.2.1. ORSA Report - requirements
- 5.1.2. Overview
- 5.2.1. Obligation to calculate Eligible Capital
- 5.4.3. Non-Compliance with the PCR
- 5.4.4. Non-Compliance with the MCR
- 5.4.5. Other regulatory actions not precluded
- 5.4.7. Eligible Capital below the level of the Capital Floor
- 5.5.1. Tier 1 Capital not to be reduced without approval
- 10.1.4. Direction regarding Eligible Capital
- 10.1.6. Certain transactions to be inquired into by Takaful Operator’s Governing Body
- 14.4.4. Eligible Capital of a Protected Cell Company
- 1.2. Purpose
- 2.1. Calculating Eligible Capital
- 2.2. Eligible Capital Calculation Table
- 4.2. Subordinated debt
- 4.3. Legal opinions on Tier 2 Capital instruments
- 5.3. Inadmissible assets
- 4.4. Excluded assets